(1)
Determining the Directions for Developing a Methodology for Comprehensive Assessment of ESG Activity in China’s Biopharmaceutical Territorial-Sectoral Complexes. meps 2025, 12, 61-74. https://doi.org/10.17308/meps/2078-9017/2025/12/61-74.